|
HDGF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.049600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.678000E-02 |
| Normal-vs-Stage2 |
1.890320E-02 |
| Normal-vs-Stage3 |
3.486600E-01 |
| Normal-vs-Stage4 |
8.284800E-01 |
| Stage1-vs-Stage2 |
2.613800E-01 |
| Stage1-vs-Stage3 |
3.386400E-01 |
| Stage1-vs-Stage4 |
1.597580E-01 |
| Stage2-vs-Stage3 |
1.237960E-01 |
| Stage2-vs-Stage4 |
5.032200E-02 |
| Stage3-vs-Stage4 |
5.795600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.332420E-01 |
| Normal-vs-AfricanAmerican |
2.748400E-01 |
| Normal-vs-Asian |
1.044390E-01 |
| Caucasian-vs-AfricanAmerican |
9.168200E-02 |
| Caucasian-vs-Asian |
5.597200E-01 |
| AfricanAmerican-vs-Asian |
3.570200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.722400E-02 |
| Normal-vs-Female |
5.591900E-02 |
| Male-vs-Female |
7.651000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.542000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.419600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.312570E-01 |
| Normal-vs-Age(81-100Yrs) |
4.746200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.005400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.779000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.563800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.595200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.475800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.759800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.385400E-01 |
| Classical-VS-Follicular |
6.79920009183377E-10 |
| Classical-VS-Other |
4.894800E-01 |
| Classical-VS-Normal |
9.524400E-01 |
| Tall-VS-Follicular |
4.160800E-04 |
| Tall-VS-Other |
4.428600E-01 |
| Tall-VS-Normal |
9.262200E-01 |
| Follicular-VS-Other |
2.517400E-01 |
| Follicular-VS-Normal |
5.90440000225456E-08 |
| Other-VS-Normal |
4.877200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.802300E-04 |
| Normal-vs-N1 |
1.478440E-01 |
| N0-vs-N1 |
2.749000E-01 |
|
|
